Treatments for Breast Cancer

Below is a listing of treatments, therapies, and surgeries for breast cancer. Click on one to read more information or connect with others currently using it.

View:
  • Ado-Trastuzumab

    Overview
    Ado-Trastuzumab Emtansine is a prescription drug approved by the Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Ado-Trastuzumab Emtansine may be pre... read more

  • Afinitor (Everolimus)

    Overview
    Afinitor is a prescription drug approved by the Food and Drug Administration (FDA) to treat advanced breast cancer in combination with Exemestane... read more

  • Arimidex (Anastrozole)

    Overview
    Arimidex is a prescription drug approved by the Food and Drug Administration (FDA) in 2008 to treat estrogen receptor-positive breast cancer in postmenopausal women. Arimidex is also known by its drug... read more

  • Aromasin (Exemestane)

    Overview
    Aromasin is a prescription drug approved by the Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer in postmenopausal women. Aromasin is also known by its drug... read more

  • Axillary lymph node dissection

    Overview
    Axillary lymph node dissection is the surgical removal of several lymph nodes, usually between five and 30, from the underarm area. It is both a diagnostic procedure performed in order to determine wh... read more

  • Bilateral Mastectomy

    Overview
    Mastectomy is surgery intended to remove all breast tissue. Mastectomy to remove one breast is referred to as unilateral mastectomy; if bot... read more

  • Chemotherapy

    Overview
    Chemotherapy is the treatment of cancer with drugs. Chemotherapy drugs may be taken intravenously or orally. Chemotherapy may be given after surgery (referred to as adjuvant chemotherapy), before surg... read more

  • Clinical Trials

    Overview
    Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for breast cancer. Clinical trials are the only way that new treatments for breast cancer ca... read more

  • Cold Cap

    Overview

    Cold caps cool the scalp to help minimize or prevent hair loss caused by chemotherapy.

    What does it involve?
    Scalp cooling works by reducing blood flow to the scalp before, during, and a... read more

  • Evista (Raloxifene)

    Overview
    Evista is a prescription drug approved by the Food and Drug Administration (FDA) in 2007 to help prevent the development of invasive breast cancer in postmenopausal women who are at high risk for the ... read more

  • Fareston (Toremifene)

    Overview
    Fareston is a prescription drug approved by the Food and Drug Administration (FDA) in 1997 to delay the progression of metastatic, estrogen receptor-positive breast cancer in postmenopausal women. Far... read more

  • Faslodex (Fulvestrant)

    Overview
    Faslodex is a prescription drug approved by the Food and Drug Administration (FDA) in 2002 to treat estrogen receptor-positive breast cancer in postmenopausal women whose cancer progressed after treat... read more

  • Femara (Letrozole)

    Overview
    Femara is a prescription drug approved by the Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer in postmenopausal women. Femara is also known by its drug nam... read more

  • Herceptin (Trastuzumab)

    Overview
    Herceptin is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy re... read more

  • Ibrance (Palbociclib)

    Overview

    Ibrance is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer in combination with Femara. Ibrance is prescribed in cases where women are postmen... read more

  • Kadcyla (Ado-Trastuzumab Emtansine)

    Overview
    Kadcyla is a prescription drug approved by the Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Kadcyla may be prescribed in cases where Trastuzumab a... read more

  • Kisqali (Ribociclib)

    Overview
    Kisqali is a prescription drug approved by the Food and Drug Administration (FDA) as an initial endocrine-based treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (H... read more

  • Lumpectomy

    Overview
    Lumpectomy, also known as breast-conserving or breast-sparing surgery, wide local excision, or partial mastectomy, is surgery to remove a breast cancer tumor along with some of the normal breast tissu... read more

  • Lynparza (Olaparib)

    Overview
    Lynparza is a prescription drug approved by the Food and Drug Administration (FDA) to treat metastatic breast cancer. Lynparza may be prescribed in either hormone receptor-positive or -negative cases,... read more

  • Mastectomy

    Overview
    Mastectomy is surgery intended to remove all breast tissue. It is used as treatment for breast cancer or as prevention for women who are at especially high risk for developing breast cancer. Mastectom... read more

Continue with Facebook
Sign up with your email
Already a Member? Log in
×

Welcome back!

Log in to gain access to the thousands of comments being shared on MyBCTeam.

log in
×